Cleared Traditional

ARCHITECT ICARBAMAZEPINE ICARBAMAZEPINE REAGENTS; ARCHITECT ICARBAMAZEPINE CALIBRATORS

K103627 · Abbott Laboratories · Toxicology
Oct 2011
Decision
305d
Days
Class 2
Risk

About This 510(k) Submission

K103627 is an FDA 510(k) clearance for the ARCHITECT ICARBAMAZEPINE ICARBAMAZEPINE REAGENTS; ARCHITECT ICARBAMAZEPINE CALIBRATORS, a Enzyme Immunoassay, Carbamazepine (Class II — Special Controls, product code KLT), submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on October 14, 2011, 305 days after receiving the submission on December 13, 2010. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3645.

Submission Details

510(k) Number K103627 FDA.gov
FDA Decision Cleared SESE
Date Received December 13, 2010
Decision Date October 14, 2011
Days to Decision 305 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code KLT — Enzyme Immunoassay, Carbamazepine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3645

Similar Devices — KLT Enzyme Immunoassay, Carbamazepine

All 55
Carbamazepine Gen 4
K151578 · Roche Diagnostics Operations (Rdo) · Oct 2015
ABBOTT CARBAMAZEPINE ASSAY
K123518 · Microgenics Corporation · Jun 2013
CARBAMAZEPINE, VALPROIC ACID, TDM CALIBRATION SET B AND ABTROL, NORTROL CONTROLS
K063131 · Thermo Electron OY · Oct 2007
ADVIA IMS CARBAMAZEPINE METHOD
K042808 · Bayer Healthcare, LLC · Feb 2005
ONLINE TDM CARBAMAZEPINE
K031902 · Roche Diagnostics Corp. · Sep 2003
RANDOX CARBAMAZEPINE
K011648 · Randox Laboratories, Ltd. · Jan 2002